MBD6 and Marchiafava-Bignami disease: However, novel and complex pathophysiology of MBD unique to kidney transplant recipients (KTRs) may occur in post-transplant MBD, which includes the effects of transplant-related drugs, carryover of MBD from the pre-transplant period, and de novo MBD6.